Total planned funding: $426,112,727
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $127,005,496 |
Mozambique | $54,381,913 |
Zambia | $42,374,624 |
Kenya | $30,181,252 |
Vietnam | $21,329,457 |
South Africa | $19,565,296 |
Tanzania | $16,027,292 |
Rwanda | $12,863,783 |
Burundi | $10,562,063 |
Haiti | $7,960,043 |
Côte d'Ivoire | $7,327,467 |
Papua New Guinea | $7,203,865 |
Uganda | $7,135,799 |
Democratic Republic of the Congo | $6,790,245 |
India | $6,388,825 |
Botswana | $5,909,720 |
Zimbabwe | $5,558,697 |
Indonesia | $5,494,394 |
Cambodia | $5,250,000 |
Angola | $4,472,878 |
Asia Regional Program | $3,727,521 |
Ethiopia | $2,799,006 |
Malawi | $2,523,759 |
Caribbean Region | $2,519,565 |
Central America Region | $2,283,457 |
South Sudan | $2,274,062 |
Dominican Republic | $1,618,747 |
China | $1,500,000 |
Eswatini | $1,394,902 |
Namibia | $450,000 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Thailand | $278,599 |
Lesotho | $250,000 |
Ghana | $0 |
Organizational Types
NGO | $418,442,727 |
Implementing Agency | $7,670,000 |
Program Areas
Treatment | $123,667,088 |
Care | $119,377,717 |
Prevention | $97,076,481 |
Testing | $43,945,879 |
Governance and Systems | $42,045,562 |
Budget Codes
HTXS: Treatment: Adult Treatment | $112,353,493 |
HBHC: Care: Adult Care and Support | $52,807,694 |
HKID: Care: Orphans and Vulnerable Children | $48,125,469 |
HVOP: Sexual Prevention: Other Sexual Prevention | $45,485,613 |
HVCT: Testing: HIV Testing and Counseling | $43,945,879 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $30,487,643 |
HLAB: Laboratory Infrastructure | $17,792,234 |
HVSI: Strategic Information | $13,928,337 |
HVTB: Care: TB/HIV | $11,818,899 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,540,376 |
OHSS: Health Systems Strengthening | $10,324,991 |
PDTX: Treatment: Pediatric Treatment | $7,890,311 |
PDCS: Care: Pediatric Care and Support | $6,625,655 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,586,200 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,194,457 |
HMIN: Biomedical Prevention: Injection Safety | $543,760 |
HMBL: Biomedical Prevention: Blood Safety | $238,432 |
Top Partner Programs
FHI 360:
$426,112,727
View countries